We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$456M
AUM Growth
+$2.09M
Cap. Flow
-$9.77M
Cap. Flow %
-2.14%
Top 10 Hldgs %
14.03%
Holding
362
New
46
Increased
61
Reduced
100
Closed
43

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.2M
2
IVZ icon
Invesco
IVZ
+$3.16M
3
DELL icon
Dell
DELL
+$2.9M
4
PFE icon
Pfizer
PFE
+$2.83M
5
JNPR
Juniper Networks
JNPR
+$2.44M

Top Sells

Rank Stock Value
1
MDP
Meredith Corporation
MDP
+$2.9M
2
VIVO
Meridian Bioscience Inc
VIVO
+$2.77M
3
CLFD icon
Clearfield
CLFD
+$2.59M
4
QCOM icon
Qualcomm
QCOM
+$2.5M
5
TRTN
Triton International Limited
TRTN
+$2.42M

Sector Composition

Rank Sector Weight
1 Healthcare 15.25%
2 Consumer Discretionary 14.74%
3 Materials 12.22%
4 Technology 12.17%
5 Consumer Staples 10.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUMN icon
151
Lumen
LUMN
$6.42B
$979K 0.21%
+78,000
New +$993K
TGNA
152
DELISTED
TEGNA Inc
TGNA
$965K 0.21%
+52,000
New +$1.04M
BFH icon
153
Bread Financial
BFH
$4.52B
$959K 0.21%
14,400
-3,643
-20% -$269K
LGIH icon
154
LGI Homes
LGIH
$1.37B
$958K 0.21%
6,200
– –
SNEX icon
155
StoneX
SNEX
$8.22B
$955K 0.21%
78,975
-77,963
-50% -$1.02M
FLG
156
Flagstar Bank National Association
FLG
$5.98B
$952K 0.21%
+26,000
New +$991K
QCOM icon
157
Qualcomm
QCOM
$169B
$951K 0.21%
5,200
-15,600
-75% -$2.5M
CNXC icon
158
Concentrix
CNXC
$1.58B
$929K 0.2%
+5,200
New +$928K
MMM icon
159
3M
MMM
$93B
$924K 0.2%
6,219
+2,511
+68% +$374K
IRWD icon
160
Ironwood Pharmaceuticals
IRWD
$706M
$909K 0.2%
+78,000
New +$957K
CLX icon
161
Clorox
CLX
$12.9B
$907K 0.2%
5,200
-1,000
-16% -$167K
ORCL icon
162
Oracle
ORCL
$417B
$907K 0.2%
10,400
+4,200
+68% +$394K
CMA
163
DELISTED
Comerica
CMA
$905K 0.2%
10,400
-5,100
-33% -$438K
PEP icon
164
PepsiCo
PEP
$188B
$903K 0.2%
5,200
– –
JNJ icon
165
Johnson & Johnson
JNJ
$619B
$890K 0.2%
+5,200
New +$851K
CL icon
166
Colgate-Palmolive
CL
$74.4B
$888K 0.19%
10,400
-11,300
-52% -$882K
SKT icon
167
Tanger
SKT
$4.6B
$887K 0.19%
+46,000
New +$875K
NBIX icon
168
Neurocrine Biosciences
NBIX
$16.2B
$886K 0.19%
10,400
-5,100
-33% -$469K
CARG icon
169
CarGurus
CARG
$3.27B
$875K 0.19%
+26,000
New +$913K
IONQ icon
170
IonQ
IONQ
$15.5B
$868K 0.19%
+52,000
New +$867K
AMZN icon
171
Amazon
AMZN
$2.95T
$867K 0.19%
5,200
+2,100
+68% +$359K
LRN icon
172
Stride
LRN
$3.34B
$867K 0.19%
+26,000
New +$898K
AMRX icon
173
Amneal Pharmaceuticals
AMRX
$5.82B
$862K 0.19%
180,000
– –
ED icon
174
Consolidated Edison
ED
$39.8B
$853K 0.19%
10,000
– –
CQP icon
175
Cheniere Energy
CQP
$32.1B
$845K 0.19%
20,000
– –
5 6
7
8 9

Similar funds

FGP
Foyston, Gordon, & Payne Toronto, Ontario, Canada $434M AUM 9.09% 1-Year Est. Return
HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Hussman Strategic Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Hussman Strategic Advisors held 362 positions worth $456M, up 0.46% from $454M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Hussman Strategic Advisors's Q4 2021 filing shows 46 new, 61 increased, 100 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M. The largest sale was Meredith Corporation, an estimated $2.9M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Hussman Strategic Advisors's largest Q4 2021 buy was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M.
  • Hussman Strategic Advisors added most to Newmont in Q4 2021, an estimated $2.27M increase.
  • Hussman Strategic Advisors's biggest Q4 2021 reduction was Clearfield, cutting an estimated $2.59M.
  • Hussman Strategic Advisors fully exited Meredith Corporation in Q4 2021, selling an estimated $2.9M.
  • Hussman Strategic Advisors's ten largest holdings make up 14% of its $456M portfolio in Q4 2021.
  • Hussman Strategic Advisors opened 46 new positions and closed 43 in Q4 2021.
  • Hussman Strategic Advisors's portfolio value rose 0.46% quarter-over-quarter to $456M.

Based on Hussman Strategic Advisors's 13F filing for Q4 2021, filed 31 Jan 2022.